Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of Use of Fitbit, Brief DSMES, and Targeted Text Messaging in Sedentary Adults With Type 2 Diabetes in Primary Care Settings

NCT07005362 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT07005362
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07005362 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of Use of Fitbit, Brief DSMES, and Targeted Text Messaging in Sedentary Adults With Type 2 Diabetes in Primary Care Settings
Lead sponsor
University of Colorado, Denver
Phase
Observational
Overall status
Completed
Start date
September 3, 2025
Completion date
August 14, 2026
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

artificial intelegence, remote patient monitoring, t2d, t2dm, t2dm (type 2 diabetes mellitus), type 2 diabetes, type 2 diabetes mellitus (t2dm)